MDX-010: Phase III started

MEDX began a U.S. Phase III trial in about 750 patients who will receive either MDX-010 in combination with MDX-1379, MDX-010 alone or MDX-1379 alone. This trial has an SPA (see BioCentury Aug. 30). ...